-
1
-
-
0026684554
-
A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
-
Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullman D, Tishler PV, Hennekens CH. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877-81.
-
(1992)
JAMA
, vol.268
, pp. 877-881
-
-
Stampfer, M.J.1
Malinow, M.R.2
Willett, W.C.3
Newcomer, L.M.4
Upson, B.5
Ullman, D.6
Tishler, P.V.7
Hennekens, C.H.8
-
2
-
-
0028845307
-
Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men
-
Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Schaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395-8.
-
(1995)
Lancet
, vol.346
, pp. 1395-1398
-
-
Perry, I.J.1
Refsum, H.2
Morris, R.W.3
Ebrahim, S.B.4
Ueland, P.M.5
Schaper, A.G.6
-
3
-
-
0029921114
-
Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
-
Den Heijer M, Koster T, Blom HJ, Bos GMJ, Briët E, Reitsma PH, Vandenbroucke JP, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-62.
-
(1996)
N Engl J Med
, vol.334
, pp. 759-762
-
-
Den Heijer, M.1
Koster, T.2
Blom, H.J.3
Bos, G.M.J.4
Briët, E.5
Reitsma, P.H.6
Vandenbroucke, J.P.7
Rosendaal, F.R.8
-
4
-
-
0028949953
-
Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis?
-
Den Heijer M, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL, Wijermans PW, Bos GMJ. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet 1995; 345: 882-5.
-
(1995)
Lancet
, vol.345
, pp. 882-885
-
-
Den Heijer, M.1
Blom, H.J.2
Gerrits, W.B.J.3
Rosendaal, F.R.4
Haak, H.L.5
Wijermans, P.W.6
Bos, G.M.J.7
-
5
-
-
0018858624
-
Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury
-
Wall TW, Harlan JM, Harker LA, Striker GE. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 1980; 18: 113-21.
-
(1980)
Thromb Res
, vol.18
, pp. 113-121
-
-
Wall, T.W.1
Harlan, J.M.2
Harker, L.A.3
Striker, G.E.4
-
6
-
-
0020520336
-
Endothelial cell dysfunction in homocystinuria
-
De Groot PG, Willems C, Boers GHJ, Gonsalves MD, Van Aken WG, Van Mourik JA. Endothelial cell dysfunction in homocystinuria. Eur J Clin Invest 1983; 13: 405-10.
-
(1983)
Eur J Clin Invest
, vol.13
, pp. 405-410
-
-
De Groot, P.G.1
Willems, C.2
Boers, G.H.J.3
Gonsalves, M.D.4
Van Aken, W.G.5
Van Mourik, J.A.6
-
7
-
-
0028907052
-
Hyperhomocysteinemia-induced vascular damage in the minipig; captopril-hydrochlorothiazide combination prevents elastic alterations
-
Rolland PH, Friggi A, Barlatier A, Piquet P, Latrille V, Faye MM, Guillou J, Charpiot P, Bodard H, Ghiringhelli O, Calaf R, Luccioni R, Carçon D. Hyperhomocysteinemia-induced vascular damage in the minipig; captopril-hydrochlorothiazide combination prevents elastic alterations. Circulation 1995; 91: 1161-74.
-
(1995)
Circulation
, vol.91
, pp. 1161-1174
-
-
Rolland, P.H.1
Friggi, A.2
Barlatier, A.3
Piquet, P.4
Latrille, V.5
Faye, M.M.6
Guillou, J.7
Charpiot, P.8
Bodard, H.9
Ghiringhelli, O.10
Calaf, R.11
Luccioni, R.12
Carçon, D.13
-
8
-
-
0030015522
-
Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia
-
Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest 1996; 98: 24-9.
-
(1996)
J Clin Invest
, vol.98
, pp. 24-29
-
-
Lentz, S.R.1
Sobey, C.G.2
Piegors, D.J.3
Bhopatkar, M.Y.4
Faraci, F.M.5
Malinow, M.R.6
Heistad, D.D.7
-
9
-
-
0028137273
-
Arterial disease in hyperhomocysteinaemia and the effect of treatment; a pilot study
-
Van den Berg M, Stehouwer CDA, Boers GHJ, Rauwerda JA, Kluft C. Arterial disease in hyperhomocysteinaemia and the effect of treatment; a pilot study. Fibrinolysis 1994; 8 (Suppl. 2): 88-90.
-
(1994)
Fibrinolysis
, vol.8
, Issue.2 SUPPL.
, pp. 88-90
-
-
Van Den Berg, M.1
Stehouwer, C.D.A.2
Boers, G.H.J.3
Rauwerda, J.A.4
Kluft, C.5
-
10
-
-
0028957460
-
Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease
-
Van den Berg M, Boers GHJ, Franken DG, Blom HJ, van Kamp GJ, Jacobs C, Rauwerda JA, Kluft C, Stehouwer CDA. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin Invest 1995; 25: 176-81.
-
(1995)
Eur J Clin Invest
, vol.25
, pp. 176-181
-
-
Van Den Berg, M.1
Boers, G.H.J.2
Franken, D.G.3
Blom, H.J.4
Van Kamp, G.J.5
Jacobs, C.6
Rauwerda, J.A.7
Kluft, C.8
Stehouwer, C.D.A.9
-
11
-
-
0028226514
-
Prospective study of endogenous tissue plasminogen activator and risk of stroke
-
Ridker PM, Hennekens CH, Stampfer MJ, Manson JAE, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343: 940-3.
-
(1994)
Lancet
, vol.343
, pp. 940-943
-
-
Ridker, P.M.1
Hennekens, C.H.2
Stampfer, M.J.3
Manson, J.A.E.4
Vaughan, D.E.5
-
12
-
-
0027274074
-
Endogenous tissue-type plasminogeen activator and risk of myocardial infarction
-
Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogeen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-8.
-
(1993)
Lancet
, vol.341
, pp. 1165-1168
-
-
Ridker, P.M.1
Vaughan, D.E.2
Stampfer, M.J.3
Manson, J.E.4
Hennekens, C.H.5
-
13
-
-
0023185776
-
Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
-
Hamsten A, Walldius G, Szamosi A, Blombäck M, De Faire U, Dahlé G, Landou C, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2: 3-9.
-
(1987)
Lancet
, vol.2
, pp. 3-9
-
-
Hamsten, A.1
Walldius, G.2
Szamosi, A.3
Blombäck, M.4
De Faire, U.5
Dahlé, G.6
Landou, C.7
Wiman, B.8
-
14
-
-
0028909230
-
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
-
Thompson SG, Kienast J, Pyke SDM, Haverkate F, Van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635-41.
-
(1995)
N Engl J Med
, vol.332
, pp. 635-641
-
-
Thompson, S.G.1
Kienast, J.2
Pyke, S.D.M.3
Haverkate, F.4
Van De Loo, J.C.W.5
-
15
-
-
0030956673
-
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
-
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens C. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9.
-
(1997)
N Engl J Med
, vol.336
, pp. 973-979
-
-
Ridker, P.M.1
Cushman, M.2
Stampfer, M.J.3
Tracy, R.P.4
Hennekens, C.5
-
16
-
-
0029805074
-
Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
-
Juhan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 1996; 94: 2057-63.
-
(1996)
Circulation
, vol.94
, pp. 2057-2063
-
-
Juhan-Vague, I.1
Pyke, S.D.M.2
Alessi, M.C.3
Jespersen, J.4
Haverkate, F.5
Thompson, S.G.6
-
17
-
-
0031054058
-
Production of C-reactive protein and risk of coronary events in stable and unstable angina
-
Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997; 349: 462-6.
-
(1997)
Lancet
, vol.349
, pp. 462-466
-
-
Haverkate, F.1
Thompson, S.G.2
Pyke, S.D.M.3
Gallimore, J.R.4
Pepys, M.B.5
-
18
-
-
0029810933
-
Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study
-
Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996; 144: 537-47.
-
(1996)
Am J Epidemiol
, vol.144
, pp. 537-547
-
-
Kuller, L.H.1
Tracy, R.P.2
Shaten, J.3
Meilahn, E.N.4
-
20
-
-
84879282750
-
Suggested standards for reports dealing with lower extremity ischemia
-
Rutherford RB, Flanigan DP, Gupta Sk, Johnston KW, Karmody A, Whittemore Baker JD, Ernst CB. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg 1986; 4: 80-94.
-
(1986)
J Vasc Surg
, vol.4
, pp. 80-94
-
-
Rutherford, R.B.1
Flanigan, D.P.2
Gupta, Sk.3
Johnston, K.W.4
Karmody, A.5
Whittemore Baker, J.D.6
Ernst, C.B.7
-
21
-
-
0025848779
-
Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
-
Ubbink JB, Vermaak WJH, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991; 565: 441-6.
-
(1991)
J Chromatogr
, vol.565
, pp. 441-446
-
-
Ubbink, J.B.1
Vermaak, W.J.H.2
Bissbort, S.3
-
22
-
-
0023150449
-
A sensitive ELISA for von Willebrand factor (vWF:Ag)
-
Ingerslev JA. A sensitive ELISA for von Willebrand factor (vWF:Ag). Scand J Clin Lab Invest 1987; 47: 143-9.
-
(1987)
Scand J Clin Lab Invest
, vol.47
, pp. 143-149
-
-
Ingerslev, J.A.1
-
23
-
-
0025284038
-
The simultaneous acute release of tissue-type plasminogen activator and von Willebrand factor in the perfused rat hindleg region
-
Tranquille N, Emeis JJ. The simultaneous acute release of tissue-type plasminogen activator and von Willebrand factor in the perfused rat hindleg region. Thromb Haemost 1990; 63: 454-8.
-
(1990)
Thromb Haemost
, vol.63
, pp. 454-458
-
-
Tranquille, N.1
Emeis, J.J.2
-
24
-
-
0026696942
-
Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus
-
Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, den Ottolander GJH. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319-23.
-
(1992)
Lancet
, vol.340
, pp. 319-323
-
-
Stehouwer, C.D.A.1
Nauta, J.J.P.2
Zeldenrust, G.C.3
Hackeng, W.H.L.4
Donker, A.J.M.5
Den Ottolander, G.J.H.6
-
25
-
-
0031045129
-
Acute von Willebrand factor secretion from the endothelium in vivo: Assessment through plasma propeptide (vWF: AgII) levels
-
Vischer UM, Ingerslev J, Wollheim CB, Mestries JC, Tsakiris DA, Haefeli WE, Kruithof EKO. Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWF: AgII) levels. Thromb Haemost 1997; 77: 387-93.
-
(1997)
Thromb Haemost
, vol.77
, pp. 387-393
-
-
Vischer, U.M.1
Ingerslev, J.2
Wollheim, C.B.3
Mestries, J.C.4
Tsakiris, D.A.5
Haefeli, W.E.6
Kruithof, E.K.O.7
-
26
-
-
0023650942
-
Localization of the cellular-fibronectin-specific epitope recognized by the monoclonal antibody IST-9 using fusion proteins expressed in E.coli
-
Carnemolla B, Borsi L, Zardi L, Owens RJ, Baralle FE. Localization of the cellular-fibronectin-specific epitope recognized by the monoclonal antibody IST-9 using fusion proteins expressed in E.coli. FEBS Letters 1987; 215: 269-73.
-
(1987)
FEBS Letters
, vol.215
, pp. 269-273
-
-
Carnemolla, B.1
Borsi, L.2
Zardi, L.3
Owens, R.J.4
Baralle, F.E.5
-
27
-
-
0029983911
-
Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy
-
Myrup B, de Maat M, Rossing P, Gram J, Kluft C, Jespersen J. Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. Thromb Haemost 1996; 81: 485-90.
-
(1996)
Thromb Haemost
, vol.81
, pp. 485-490
-
-
Myrup, B.1
De Maat, M.2
Rossing, P.3
Gram, J.4
Kluft, C.5
Jespersen, J.6
-
28
-
-
0028921263
-
Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction
-
Haverkate F, Thompson SG, Duckert F. Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Thromb Haemost 1995; 73: 561-7.
-
(1995)
Thromb Haemost
, vol.73
, pp. 561-567
-
-
Haverkate, F.1
Thompson, S.G.2
Duckert, F.3
-
29
-
-
0017197285
-
Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis
-
Harker LA, Ross R, Slichter SJ, Scott CR. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976; 58: 731-41.
-
(1976)
J Clin Invest
, vol.58
, pp. 731-741
-
-
Harker, L.A.1
Ross, R.2
Slichter, S.J.3
Scott, C.R.4
-
30
-
-
0029869178
-
Increased cyclin dependent kinase in aortic tissue of rats fed homocysteine
-
Lubec B, Arbeiter K, Hoeger H, Lubec G. Increased cyclin dependent kinase in aortic tissue of rats fed homocysteine. Thromb Haemostas 1996; 75: 542-5.
-
(1996)
Thromb Haemostas
, vol.75
, pp. 542-545
-
-
Lubec, B.1
Arbeiter, K.2
Hoeger, H.3
Lubec, G.4
-
31
-
-
0000487436
-
Homocysteine theory of arteriosclerosis: Development and current status
-
McCully KS. Homocysteine theory of arteriosclerosis: development and current status. Atheroscler Rev 1983; 11: 157-246.
-
(1983)
Atheroscler Rev
, vol.11
, pp. 157-246
-
-
McCully, K.S.1
-
32
-
-
0031018333
-
Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans
-
Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997; 95: 1119-21.
-
(1997)
Circulation
, vol.95
, pp. 1119-1121
-
-
Tawakol, A.1
Omland, T.2
Gerhard, M.3
Wu, J.T.4
Creager, M.A.5
-
33
-
-
0026478022
-
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
-
Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.
-
(1992)
Lancet
, vol.340
, pp. 1111-1115
-
-
Celermajer, D.S.1
Sorensen, K.E.2
Gooch, V.M.3
Spiegelhalter, D.J.4
Miller, O.I.5
Sullivan, I.D.6
Lloyd, J.K.7
Deanfield, J.E.8
-
34
-
-
0022345887
-
Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetec microvascular disease
-
Solerte SB, Piovella F, Viola C, Schianca GC, Gamba G, Fioravanti M, Ferrari E. Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetec microvascular disease. Acta Diabetol Lat 1985; 22: 239-46.
-
(1985)
Acta Diabetol Lat
, vol.22
, pp. 239-246
-
-
Solerte, S.B.1
Piovella, F.2
Viola, C.3
Schianca, G.C.4
Gamba, G.5
Fioravanti, M.6
Ferrari, E.7
-
35
-
-
0029142708
-
Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular disease
-
Blann AD, Maxwell SRJ, Burrows G, Miller JP. Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular disease. Atherosclerosis 1995; 116: 191-8.
-
(1995)
Atherosclerosis
, vol.116
, pp. 191-198
-
-
Blann, A.D.1
Maxwell, S.R.J.2
Burrows, G.3
Miller, J.P.4
-
36
-
-
0029121091
-
Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication
-
Stroes ESG, Koomans HA, de Bruin TWA, Rabelink TJ. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 1995; 346: 467-71.
-
(1995)
Lancet
, vol.346
, pp. 467-471
-
-
Stroes, E.S.G.1
Koomans, H.A.2
De Bruin, T.W.A.3
Rabelink, T.J.4
|